Analysis revealed that FAM50A was significantly overexpressed in various tumors, including bladder urothelial carcinoma, colon cancer, rectal cancer, and other common tumor types (P <  0.05, Figs 1A and 1B). This evidence concerns the gene FAM50A and bladder transitional cell carcinoma.